| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
3 companies
Parsey Merdad is a Chief Medical Officer at GILD, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 19 sales. Those positions are worth an estimated $11.8M at current prices.
Our model assigns Parsey Merdad a middling insider score of 52/100, based on 13 past trades. Over a 12-month horizon, 30.8% of those trades were profitable, with an average 12-month return of -25.8%.
Parsey Merdad's largest disclosed position is in GILD as Chief Medical Officer, worth about $11.4M. The recent filings there lean toward selling, a net 250,108 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sale+OE | 164,211 | $91.92 | $15,094,013.40 | -22.9% | +20.7% | +36.2% | |
| Nov 6, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sale+OE | 25,590 | $91.50 | $2,341,485.00 | -11.1% | +6.9% | +34.6% | |
| Oct 1, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 2,000 | $83.83 | $167,660.00 | -2.0% | +9.6% | +32.4% | |
| Sep 12, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sale+OE | 21,246 | $84.50 | $1,795,287.00 | -17.2% | +11.1% | +37.7% | |
| Jul 1, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 2,000 | $68.63 | $137,260.00 | -2.0% | +22.1% | +62.8% | |
| Apr 1, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 2,000 | $72.96 | $145,920.00 | -2.0% | -5.8% | +52.7% | |
| Feb 29, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 10,230 | $72.82 | $744,983.86 | -5.0% | -11.9% | +58.5% | |
| Sep 12, 2023 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 1,501 | $76.99 | $115,561.99 | -2.1% | +4.3% | +5.4% | |
| Jun 13, 2023 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 1,485 | $76.90 | $114,196.50 | -4.8% | -1.8% | -18.0% | |
| Mar 13, 2023 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 6,126 | $78.99 | $483,892.74 | -8.0% | -2.1% | -5.6% |